Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc. (GANX) Stock Ticker

NASDAQ: GANX · Healthcare · Biotechnology
$1.78-3.26%
USD · as of 2026-09-27 · market cap $75.9M
Open GANX in TickrDownload for iPhone

GANX right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±23.1%
Options expect by Oct 29±47.7%
Priced in for Nov 11 earnings±57.1%
IV rank (30-day)71% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full GANX picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on GANX
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Gain Therapeutics, Inc.

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed proteins. Subsequently, Gain Therapeutics identifies proprietary small molecules designed to bind to these locations, thereby restoring correct protein conformation and alleviating the disease. Their current development pipeline includes several structurally targeted allosteric regulator candidates aimed at combating a range of diseases, such as Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1. Established in 2017, the company is headquartered in Bethesda, Maryland.

GANX stock facts

Ticker symbolGANX
ExchangeNASDAQ Global Market
SectorHealthcare
IndustryBiotechnology
Market cap$75.9M
CEOGene Mack
Employees21
HeadquartersBethesda, MD, US
IPO date2021-03-19
Websitewww.gaintherapeutics.com

What you can see for GANX on Tickr

Live GANX price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the GANX report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Gain Therapeutics, Inc.?

The ticker symbol for Gain Therapeutics, Inc. is GANX, listed on the NASDAQ Global Market.

What is GANX?

Gain Therapeutics, Inc. is a biotechnology firm specializing in the creation of advanced treatments for conditions originating from improperly folded proteins. The company primarily directs its efforts towards rare genetic disorders and neurological ailments. It employs its unique Site-Directed Enzyme Enhancement Therapy (SEE-Tx) platform to pinpoint specific allosteric sites on malformed…

HomeExploreMarketLists
All pages